14th Joint European Medicines Agency/European network for Health Technology Assessment dialogue meeting

Date: 15/12/2017
Location: European Medicines Agency, London, UK
The EMA and EUnetHTA have been holding regular dialogue since 2010. The key topics of this meeting are concepts related to orphan medicines (significant benefit vs relative effectiveness), opportunities for collaboration on horizon scanning, reflections on the concept of evidence transfer / extrapolation, principles of the working of the indication as well as ongoing initiatives on post-licensing evidence generation. A report from the meeting will be published later.

How useful was this page?

Add your rating